Sat, Oct 25, 2014, 5:30 AM EDT - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

ImmunoCellular Therapeutics, Ltd. Message Board

  • futurestrader52 futurestrader52 Jan 26, 2010 6:44 PM Flag

    Holy cow

    I was off by around 15 million shares on the potential shares outstanding. I thought maybe around 38 million but it looks like 53-54 million fully diluted. I sure hope this company knows what it is doing. They're on track to be a hundred million dollar market cap with the price never getting above 1. The hedging could hold the stock at 1 for a long, long, time. I'm not going to buy anymore. If it sells off and management resets their option exercise price then I would be extremely disappointed from an investor point of view. The only thing I now see is the positive trial results and that my friends is what we need...even if we don't make money investing with IMUC the payoff for the cancer patients is all worth it.

    SortNewest  |  Oldest  |  Most Replied Expand all replies

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.